Literature DB >> 2536981

Specific sequence deletions in two classes of murine leukemia virus-related proviruses in the mouse genome.

L Y Ch'ang1, W K Yang, F E Myer, C K Koh, L R Boone.   

Abstract

Characteristic long terminal repeats (LTR) of approximately 700 and 750 bp were found, respectively, in the two classes (polytropic and modified polytropic) of murine leukemia virus (MuLV)-related nonecotropic nonxenotropic proviral sequences in eight individual molecular clones of RFM/Un mouse chromosomal DNA fragments. Three proviral clones, two polytropic and one modified polytropic, contained sequence deletions in the viral structural genes. Nucleotide sequence analysis revealed that 7-bp direct repeats occur at both ends of deleted sequences in intact structures and one of the repeats remains in genomes with the deletion. Specifically, the deleted sequences were a 1487-bp gag-pol sequence with ACTGCCC repeat, a 113-bp mid-pol sequence with CAGGCAA repeat, and a 1811-bp env sequence with GGTCCAG repeat. The same specific sequence deletions were found in both classes of MuLV-related proviral structures. Examination of chromosomal DNA from eight inbred laboratory mouse strains and six wild mouse species showed that a minor population of proviruses with these specific deletions were present in Mus musculus and Mus spretus, all of which contain prominent 700-bp LTR polytropic proviral structures. The 750-bp LTR modified polytropic proviral structures were phylogenetically more restricted, being equally predominant in Mus musculus domesticus mice, but minor to undetectable in Mus spretus subspecies, and absent in other wild mouse populations.

Entities:  

Mesh:

Year:  1989        PMID: 2536981     DOI: 10.1016/0042-6822(89)90264-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Structures of endogenous nonecotropic murine leukemia virus (MLV) long terminal repeats in wild mice: implication for evolution of MLVs.

Authors:  K Tomonaga; J M Coffin
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Structure and distribution of endogenous nonecotropic murine leukemia viruses in wild mice.

Authors:  K Tomonaga; J M Coffin
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  Analysis of thymic endogenous retroviral expression in murine lupus. Genetic and immune studies.

Authors:  A M Krieg; A D Steinberg
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

4.  Evolution of functional and sequence variants of the mammalian XPR1 receptor for mouse xenotropic gammaretroviruses and the human-derived retrovirus XMRV.

Authors:  Yuhe Yan; Qingping Liu; Kurt Wollenberg; Carrie Martin; Alicia Buckler-White; Christine A Kozak
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

5.  A linkage map of endogenous murine leukemia proviruses.

Authors:  W N Frankel; J P Stoye; B A Taylor; J M Coffin
Journal:  Genetics       Date:  1990-02       Impact factor: 4.562

6.  Antigenic subclasses of polytropic murine leukemia virus (MLV) isolates reflect three distinct groups of endogenous polytropic MLV-related sequences in NFS/N mice.

Authors:  Leonard H Evans; Marc Lavignon; Marc Taylor; A S M Alamgir
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Characterization of the endogenous nonecotropic murine leukemia viruses of NZB/B1NJ and SM/J inbred strains.

Authors:  W N Frankel; B K Lee; J P Stoye; J M Coffin; E M Eicher
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

8.  Characterization of recombinant nonecotropic murine leukemia viruses from the wild mouse species Mus spretus.

Authors:  Yong Tae Jung; Tiyun Wu; Christine A Kozak
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

9.  Wild mouse variants of envelope genes of xenotropic/polytropic mouse gammaretroviruses and their XPR1 receptors elucidate receptor determinants of virus entry.

Authors:  Yuhe Yan; Ryan C Knoper; Christine A Kozak
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.